½ÃÀ庸°í¼­
»óǰÄÚµå
1602312

¼¼°èÀÇ ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°-¿¹Ãø(2025-2030³â)

4D Printing in Healthcare Market by Component (Equipment, Programmable Materials), Technology (Fused Deposition Modelling, Polyjet, Selective Laser Sintering), Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀº 2023³â¿¡ 2,743¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 3,187¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 16.30%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 7,898¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃÀ̶õ, ½Ã°£ÀÇ Â÷¿øÀ» µµÀÔÇÑ 3D ÇÁ¸°ÆÃÀÇ °íµµÀÇ ÁøÈ­¸¦ ÀǹÌÇϸç, ¿Âµµ, ½À±â, ºû µîÀÇ È¯°æ Àڱؿ¡ ÀÇÇØ ÇÁ¸°Æ®µÈ ¹°Ã¼°¡ Á¦Á¶ ÈÄ¿¡ Çü»óÀ̳ª ±â´ÉÀ» º¯È­½ÃŰ´Â °ÍÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ Àû¿ë ¹üÀ§´Â ½º¸¶Æ® Á¦¾à ½Ã½ºÅÛ, ¹ÝÀÀ¼º »ýü Àç·á, µ¿Àû ÀÓÇöõÆ® µîÀ» Æ÷ÇÔÇϳª ÀÌ¿¡ ÇÑÁ¤µÇ´Â °ÍÀº ¾Æ´Õ´Ï´Ù. 4D ÇÁ¸°ÆÃÀÇ Çʿ伺Àº ¿ì¼öÇÑ ¼º´É°ú ȯÀÚ °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ´Â °³ÀÎÈ­µÈ Áö´ÉÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ¹ß»ýÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Àڱ⠺¹±¸ Àç·á, ¸ÂÃãÇü Àΰø À屸, °íµµ·Î Á¶Á¤µÈ ÀÌ½Ä °¡´ÉÇÑ ÀåÄ¡, µ¿ÀûÀÎ Á¶Á÷ °øÇÐ¿ë ¹ßÆÇÀÇ ÀÛ¼º¿¡ ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, ¿¬±¸ ±â°ü, ±â¼úÀû Áøº¸¸¦ ¸ñÇ¥·Î ÇÏ´Â ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ±â¾÷ µîÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 2,743¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 3,187¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 7,898¸¸ ´Þ·¯
CAGR(%) 16.30%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â Àç·á °úÇÐÀÇ ±â¼ú Áøº¸, ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡, ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ µîÀÌ Æ÷ÇԵ˴ϴÙ. ȯÀÚ¿¡°Ô ƯȭµÈ Ä¡·áÀÇ ´ëµÎ¿Í ºñ¿ë È¿°úÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÏ´Â °ÍÀº Å« ºñÁî´Ï½º ±âȸÀÔ´Ï´Ù. ¿¬±¸±â°ü°ú ÇコÄɾî Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû Á¦ÈÞ´Â ±â¼úÀÇ ½Å¼ÓÇÑ Çõ½Å°ú ä¿ëÀ» ÃËÁøÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱâ ÅõÀÚ ºñ¿ë, º¹ÀâÇÑ Á¦Á¶ ÇÁ·Î¼¼½º, ¾ö°ÝÇÑ ±ÔÁ¦ÀÇ °ñÁ¶¶ó°í ÇÏ´Â °úÁ¦°¡, ½ÃÀå È®´ëÀÇ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼úÀûÀÎ Àü¹®Áö½ÄÀÌ ºÎÁ·ÇÑ Á¡À̳ª È®À强¿¡ ¹®Á¦°¡ ÀÖ´Â Á¡ µîµµ ÇѰèÁ¡À¸·Î ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å°ú ¿¬±¸ÀÇ °¡Àå À¯¸ÁÇÑ ºÐ¾ß´Â »ý»ê °øÁ¤ÀÇ ¼Óµµ¿Í ºñ¿ë È¿À²¼º Çâ»ó°ú ÇÔ²² ¹ÝÀÀ¼º°ú »ýü ÀûÇÕ¼ºÀ» °³¼±ÇÒ ¼ö ÀÖ´Â »õ·Î¿î ½º¸¶Æ® ¼ÒÀçÀÇ °³¹ßÀÔ´Ï´Ù. °Ô´Ù°¡ ½Ã¹Ä·¹ÀÌ¼Ç ¼ÒÇÁÆ®¿þ¾î¿Í ȯÀÚº° ¸ðµ¨¸µÀ» À§ÇÑ ÅëÇÕ ½Ã½ºÅÛÀÇ Áøº¸´Â ±â¼ú Çõ½ÅÀ» ÃßÁøÇϴµ¥ À־ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ½ÃÀå »óȲÀº À¯¸ÁÇÏÁö¸¸, ³«°üÇÒ ¼ö¸¸Àº ¾ø´Â »óȲÀ̸ç, ȯÀÚ ÄɾîÀÇ ÆÐ·¯´ÙÀÓÀ» º¯È­½Ãų °¡´É¼ºÀ» ÃæºÐÈ÷ Ȱ¿ëÇϱâ À§Çؼ­´Â ±â¼úÀû ¹× ±ÔÁ¦Àû Àå¾Ö¹°À» ±Øº¹Çϱâ À§ÇÑ ÁýÁßÀû Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç °áÁ¤, »õ·Î¿î ºñÁî´Ï½º Âù½ºÀÇ È¹µæÀ» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Æ÷°ýÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ºñ¿ëÀ̳ª ±¸¸Åµ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÈÞ¸Õ ½ºÄÉÀÏ »ýü Àç·á, È­ÇÐ ¿ä¹ý, Á¶Á÷ °øÇп¡ Å« ¿ëµµ
    • 3D ÇÁ¸°ÆÃ ¼­ºñ½ºÀÇ ±â¼ú Çõ½Å°ú Áøº¸
    • 3D ±â¹Ý ÀÇ·á±â±â¿¡¼­ 4D ±â¹ÝÀ¸·Î ¼ÒºñÀÚÀÇ ±âÈ£ÀÇ º¯È­
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±ÔÁ¦ ±âÁØ ¹× ¼º´É ±âÁØ¿¡ ÁذÅ
    • °³¹ß ¹× Á¦Á¶¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • Ç¥Àû ¾à¹° Àü´ÞÀ» À§ÇÑ 4D ÇÁ¸°ÆÃ ¿ëµµ °³¹ß
    • Àå±â À̽ÄÀ̳ª Ä¡°ú¿¡ ´ëÇÑ ¿ëµµ¿¡¼­ ¼ö¿ä Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ÀáÀçÀûÀÎ ¾ÈÀü»óÀÇ À§Ç輺

Porter's Five Forces : ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÆÇµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡¿¡ ´ëóÇϸç, ÀáÀçÀûÀÎ °úÁ¦¸¦ ȸÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎÀÇ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ±âÈ£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ» ³»´Ùº» Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÔÀ¸·Î½á °æÀï»óÀÇ Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕÀÇ µ¿ÇâÀÌ ¹àÇôÁ® º¥´õ´Â °æÀïÀÌ °ÝÈ­µÇ´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ½Ç½ÃÇϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡Çϱâ À§ÇÑ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ¹ÙÅÁÀ¸·Î Æò°¡ÇÔÀ¸·Î½á ¸ñÇ¥¿¡ µû¸¥ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼±×¸ÕƮȭÇϰí, Àü·« ¸ñÇ¥¿¡ ÃÖÀûÀÎ ÆÄÆ®³Ê³ª ¼Ö·ç¼ÇÀ» ƯÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â, ½ÇÀû ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇÏ°í °³¼±¿¡ ÀÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï Á¤¼¼ÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÎ±â À§ÇÑ Ã¼Á¦¸¦ °®Ãâ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àΰ£ ±Ô¸ðÀÇ »ýü Àç·á, È­ÇÐ ¿ä¹ý, Á¶Á÷ °øÇп¡ Áß¿äÇÑ ¿ëµµ
      • 3D ÇÁ¸°ÆÃ ¼­ºñ½ºÀÇ ±â¼ú Çõ½Å°ú ¹ßÀü
      • ¼ÒºñÀÚÀÇ ±âÈ£°¡ 3D ±â¹Ý ÀÇ·á±â±â·ÎºÎÅÍ 4D ±â¹Ý ÀÇ·á±â±â·Î ÀÌÇà
    • ¾ïÁ¦¿äÀÎ
      • ±ÔÁ¦ ¹× ¼º´É ±âÁØ Áؼö
      • °³¹ß°ú »ý»ê¿¡ µå´Â ³ôÀº ºñ¿ë
    • ±âȸ
      • Ÿ°Ù ¾à¹°Àü´ÞÀ» À§ÇÑ 4D ÇÁ¸°Æ® ¿ëµµ °³¹ß
      • Àå±â À̽İú Ä¡°ú¿¡ ´ëÇÑ ¿ëµµ ¼ö¿ä Áõ°¡
    • °úÁ¦
      • ÀáÀçÀûÀÎ ¾ÈÀü»óÀÇ À§Çè
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ÀåÄ¡
    • 3D ¹ÙÀÌ¿À ÇÁ¸°ÅÍ
    • 3D ÇÁ¸°ÅÍ
  • ÇÁ·Î±×·¥ °¡´ÉÇÑ Àç·á
    • ÇÏÀ̵å·Î°Ö
    • »ì¾ÆÀÖ´Â ¼¼Æ÷
    • Çü»ó ±â¾ï Àç·á

Á¦7Àå ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå : ±â¼úº°

  • ¿­¿ëÇØ ÀûÃþ¹ý
  • Æú¸®Á¦Æ®
  • ¼±ÅÃÀû ·¹ÀÌÀú ¼Ò°á
  • ½ºÅ×·¹¿À ¸®¼Ò±×·¡ÇÇ

Á¦8Àå ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå : ¿ëµµº°

  • ÀÇ·á ¹× Á¶»ç ¸ðµ¨
  • ȯÀÚ °íÀ¯ÀÇ ÀÓÇöõÆ®
  • ¼ö¼ú °¡À̵å

Á¦9Àå ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ä¡°ú±â°ø¼Ò
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °Ç°­ °ü¸®ÀÇ 4D ÇÁ¸°ÆÃ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄɾî¿ë 4D ÇÁ¸°ÆÃ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3D HUBS BV
  • 3D Systems, Inc.
  • Anatomiz3D Medtech Private Limited
  • CELLINK Bioprinting AB
  • Dassault Systemes SE
  • Desktop Metal Inc.
  • EOS GmbH
  • Formlabs Inc.
  • Materialise NV
  • Organovo Holdings, Inc.
  • Osteo3d
  • Poietis-4D Bioprinting
  • Sinterex 3D Printing Manufacturing LLC
  • Stratasys, Ltd.
  • Tractus3D
AJY 24.12.06

The 4D Printing in Healthcare Market was valued at USD 27.43 million in 2023, expected to reach USD 31.87 million in 2024, and is projected to grow at a CAGR of 16.30%, to USD 78.98 million by 2030.

4D Printing in healthcare refers to the advanced evolution of 3D printing that incorporates the dimension of time, allowing printed objects to change shape or function after production through environmental stimuli such as temperature, moisture, or light. The scope of 4D Printing in healthcare includes but is not limited to smart pharmaceutical systems, responsive biomaterials, and dynamic implants, offering precision and adaptability significantly beyond traditional methods. The necessity of 4D Printing arises from the growing demand for personalized and intelligent healthcare solutions capable of offering superior performance and improved patient outcomes. This technology finds its application in creating self-healing materials, custom prosthetics, highly tailored implantable devices, and dynamic tissue engineering scaffolds. End users predominantly include hospitals, research institutions, and biotech companies striving for technological advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 27.43 million
Estimated Year [2024] USD 31.87 million
Forecast Year [2030] USD 78.98 million
CAGR (%) 16.30%

Market insights suggest that key growth factors include technological advancements in materials science, an increase in R&D investments, and the burgeoning demand for customized medical solutions. The rise of patient-specific treatments and the growing need for cost-effective healthcare solutions present considerable opportunities. Strategic collaborations between research entities and healthcare providers can facilitate rapid innovation and adoption of technology. However, challenges such as high initial investment costs, complex manufacturing processes, and stringent regulatory frameworks pose significant barriers to market expansion. Limitations also include insufficient technical expertise and scalability issues.

The most promising areas for innovation and research are the development of new smart materials that can improve responsiveness and biocompatibility, alongside improving the speed and cost-efficiency of production processes. Additionally, advancements in simulation software and integrated systems for patient-specific modeling are crucial for driving innovation. Overall, the market for 4D Printing in healthcare shows a promising yet cautiously optimistic landscape, necessitating a focused approach on overcoming technological and regulatory hurdles to fully harness its potential in transforming patient care paradigms.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 4D Printing in Healthcare Market

The 4D Printing in Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant application in human scale biomaterials, chemotherapy, and tissue engineering
    • Innovations and advancements in technology for 3D printing services
    • Shift in consumer preference from 3D-based medical devices to 4D-based
  • Market Restraints
    • Complying with regulatory and performance standards
    • High cost associated with the development and production
  • Market Opportunities
    • Development of 4D printing applications for targeted drug delivery
    • Growing demand in organ transplants and applications in dentistry
  • Market Challenges
    • Potential safety hazards

Porter's Five Forces: A Strategic Tool for Navigating the 4D Printing in Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 4D Printing in Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 4D Printing in Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 4D Printing in Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 4D Printing in Healthcare Market

A detailed market share analysis in the 4D Printing in Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 4D Printing in Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 4D Printing in Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 4D Printing in Healthcare Market

A strategic analysis of the 4D Printing in Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 4D Printing in Healthcare Market, highlighting leading vendors and their innovative profiles. These include 3D HUBS B.V., 3D Systems, Inc., Anatomiz3D Medtech Private Limited, CELLINK Bioprinting AB, Dassault Systemes SE, Desktop Metal Inc., EOS GmbH, Formlabs Inc., Materialise NV, Organovo Holdings, Inc., Osteo3d, Poietis - 4D Bioprinting, Sinterex 3D Printing Manufacturing LLC, Stratasys, Ltd., and Tractus3D.

Market Segmentation & Coverage

This research report categorizes the 4D Printing in Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Equipment and Programmable Materials. The Equipment is further studied across 3D Bioprinter and 3D Printer. The Programmable Materials is further studied across Hydrogel, Living Cells, and Shape-Memory Materials.
  • Based on Technology, market is studied across Fused Deposition Modelling, Polyjet, Selective Laser Sintering, and Stereolithography.
  • Based on Application, market is studied across Medical & Research Models, Patient-Specific Implant, and Surgical Guide.
  • Based on End User, market is studied across Dental Laboratory and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant application in human scale biomaterials, chemotherapy, and tissue engineering
      • 5.1.1.2. Innovations and advancements in technology for 3D printing services
      • 5.1.1.3. Shift in consumer preference from 3D-based medical devices to 4D-based
    • 5.1.2. Restraints
      • 5.1.2.1. Complying with regulatory and performance standards
      • 5.1.2.2. High cost associated with the development and production
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of 4D printing applications for targeted drug delivery
      • 5.1.3.2. Growing demand in organ transplants and applications in dentistry
    • 5.1.4. Challenges
      • 5.1.4.1. Potential safety hazards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 4D Printing in Healthcare Market, by Component

  • 6.1. Introduction
  • 6.2. Equipment
    • 6.2.1. 3D Bioprinter
    • 6.2.2. 3D Printer
  • 6.3. Programmable Materials
    • 6.3.1. Hydrogel
    • 6.3.2. Living Cells
    • 6.3.3. Shape-Memory Materials

7. 4D Printing in Healthcare Market, by Technology

  • 7.1. Introduction
  • 7.2. Fused Deposition Modelling
  • 7.3. Polyjet
  • 7.4. Selective Laser Sintering
  • 7.5. Stereolithography

8. 4D Printing in Healthcare Market, by Application

  • 8.1. Introduction
  • 8.2. Medical & Research Models
  • 8.3. Patient-Specific Implant
  • 8.4. Surgical Guide

9. 4D Printing in Healthcare Market, by End User

  • 9.1. Introduction
  • 9.2. Dental Laboratory
  • 9.3. Hospitals & Clinics

10. Americas 4D Printing in Healthcare Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific 4D Printing in Healthcare Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa 4D Printing in Healthcare Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D HUBS B.V.
  • 2. 3D Systems, Inc.
  • 3. Anatomiz3D Medtech Private Limited
  • 4. CELLINK Bioprinting AB
  • 5. Dassault Systemes SE
  • 6. Desktop Metal Inc.
  • 7. EOS GmbH
  • 8. Formlabs Inc.
  • 9. Materialise NV
  • 10. Organovo Holdings, Inc.
  • 11. Osteo3d
  • 12. Poietis - 4D Bioprinting
  • 13. Sinterex 3D Printing Manufacturing LLC
  • 14. Stratasys, Ltd.
  • 15. Tractus3D
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦